Ignite Creation Date:
2025-12-25 @ 4:04 AM
Ignite Modification Date:
2026-02-24 @ 5:39 PM
Study NCT ID:
NCT03482102
Status:
RECRUITING
Last Update Posted:
2022-09-08
First Post:
2018-03-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Durvalumab (MEDI4736) and Tremelimumab and Radiation Therapy in Hepatocellular Carcinoma and Biliary Tract Cancer
Sponsor:
Massachusetts General Hospital
Organization: